2011 annual financial data
Heron Therapeutics 2011 Operating margin
Direct answer
Operating margin was -1,712.38%.
Operating income was -11,062,000 USD and net income was -11,814,000 USD.
Operating cash flow was -7,721,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 646,000 USD
- Operating income
- -11,062,000 USD
- Net income
- -11,814,000 USD
- Operating cash flow
- -7,721,000 USD